An obvious paradox was observed in patients with severe COVID-19 that some individuals had high levels of serum interferon α (IFNα) and potentially neutralizing antibodies but low ISG-signature scores, indicating that the sera from patients with severe COVID-19 might contain certain substances that could suppress the IFN response. The gene discussed is IFNA1; the disease is COVID-19.